lobbying_activities: 831888

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
831888	0ca271c1-62e4-45b3-9e9b-5024186ca08c	Q3	EISAI INC.	400321512	EISAI INC.	2009	third_quarter	PHA	Establishment of pathway for the approval of biosimilars in health reform legislation HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act HR 1548, Pathway for Biosimilars Act S. 369, Preserve Acess to Affordable Generics Act S. 726, Promoting Innovation and Access to Life-Saving Medicine Act	HOUSE OF REPRESENTATIVES,SENATE		810000	0	0	2009-10-16T12:47:59-04:00